California Public Employees Retirement System
URGN icon

California Public Employees Retirement System’s UroGen Pharma URGN Stock Holding History

California Public Employees Retirement System’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39,400
Closed -$768K – 2862
2021
Q1 		$768K Hold
39,400
– – ﹤0.01% 2679
2020
Q4 		$710K Sell
39,400
-800
-2% -$16.8K ﹤0.01% 2704
2020
Q3 		$775K Buy
40,200
+1,000
+3% +$22.6K ﹤0.01% 2462
2020
Q2 		$1.02M Sell
39,200
-2,698
-6% -$65.9K ﹤0.01% 2228
2020
Q1 		$747K Buy
41,898
+5,998
+17% +$162K ﹤0.01% 2170
2019
Q4 		$1.2M Buy
35,900
+16,500
+85% +$450K ﹤0.01% 2275
2019
Q3 		$462K Buy
19,400
+4,300
+28% +$141K ﹤0.01% 2596
2019
Q2 		$543K Buy
15,100
+1,300
+9% +$47.9K ﹤0.01% 2501
2019
Q1 		$510K Hold
13,800
– – ﹤0.01% 2551
2018
Q4 		$594K Sell
13,800
-1,662
-11% -$74.7K ﹤0.01% 2482
2018
Q3 		$730K Sell
15,462
-1,423
-8% -$66.1K ﹤0.01% 2503
2018
Q2 		$840K Buy
+16,885
New +$983K ﹤0.01% 2416

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

California Public Employees Retirement System's URGN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of UroGen Pharma (URGN) in Q2 2021, closing a stake of 39,400 shares — an estimated $768K sold.

California Public Employees Retirement System first reported a position in URGN in Q2 2018 and held it in 12 quarters. The position peaked at $1.2M in Q4 2019. 82 funds tracked by Wall St. Rank hold URGN as of Q2 2021.

  • California Public Employees Retirement System reported no remaining UroGen Pharma position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 39,400 UroGen Pharma shares in Q2 2021, an estimated $768K.
  • California Public Employees Retirement System first reported a position in UroGen Pharma in Q2 2018 and held it in 12 quarters.
  • California Public Employees Retirement System's UroGen Pharma position peaked at $1.2M in Q4 2019.
  • 82 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.